Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On
Changes made to transferable exclusivity vouchers (TEVs) for antimicrobials, introduced as part of the EU pharmaceutical legislative reform package, will “weaken” their value to the point that they ar
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Daiichi Sankyo Tries Wayfinder’s
Gilead Sciences’ lenacapavir is already expected to have a significant advantage among injected HIV drugs thanks to its twice-yearly injection schedule when the company launches it for pre-exposure pr